Spring Research Update Meeting 2025: watch again
Our 2025 Spring Research Update Meeting took place at BMA House, home of the British Medical Association, in Tavistock Square, London on 24 March where we invited guests to an inspiring agenda of some of the most up to date news of our funded research....
Learn more
Exenatide and Parkinson’s
The Exenatide-PD3 study was a phase 3 clinical trial of Type 2 diabetes drug exenatide (Bydureon) which finished in early 2024. The results of this trial have now been published and they indicate that the study did not slow the progression of Parkinson’s compared to...